Literature DB >> 17659375

Regulation of T cell homeostasis by JAKs and STATs.

Jeremy A Ross1, Zsuzsanna S Nagy, Hanyin Cheng, Stanislaw M Stepkowski, Robert A Kirken.   

Abstract

Regulation of T cell homeostasis is critical for maintaining normal immune function. An imbalance in T cell proliferation can result in disorders ranging from cancer and autoimmunity to immunodeficiencies. Full activation of T cells requires three sequential signals, where signal 3, which is delivered by multiple cytokines, regulates proliferation, differentiation, and survival/death. Signaling from cytokines through their receptors is primarily delivered by two molecular families, namely Janus tyrosine kinases (JAKs) and signal transducers and activators of transcription (STATs). Invaluable knowledge about JAKs and STATs has arisen from studies of mice made genetically deficient in these molecules, analyses of tumor models, and studies of expression patterns by proteomics/genomics, which all have begun to define the role of JAKs and STATs in survival versus apoptosis. These findings also have suggested ways in which JAKs and STATs may be manipulated for therapeutic intervention in lymphoid-derived diseases. This review seeks to focus on the role of JAK tyrosine kinases and STAT transcription factors in mediating the lymphocyte life cycle and how they might be manipulated for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659375     DOI: 10.1007/s00005-007-0030-x

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  17 in total

1.  IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.

Authors:  Roozbeh Sharif; Maureen D Mayes; Filemon K Tan; Olga Y Gorlova; Laura Kathleen Hummers; Ami A Shah; Daniel E Furst; Dinesh Khanna; Javier Martin; Lara Bossini-Castillo; Emilio B Gonzalez; Jun Ying; Hilda Torres Draeger; Sandeep K Agarwal; John D Reveille; Frank C Arnett; Fredrick M Wigley; Shervin Assassi
Journal:  Ann Rheum Dis       Date:  2012-03-22       Impact factor: 19.103

2.  Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

Authors:  M Cecilia Albareda; Damián Perez-Mazliah; M Ailén Natale; Melisa Castro-Eiro; María G Alvarez; Rodolfo Viotti; Graciela Bertocchi; Bruno Lococo; Rick L Tarleton; Susana A Laucella
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

3.  IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.

Authors:  M Czystowska; J Han; M J Szczepanski; M Szajnik; K Quadrini; H Brandwein; J W Hadden; K Signorelli; T L Whiteside
Journal:  Cell Death Differ       Date:  2009-01-30       Impact factor: 15.828

4.  Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation.

Authors:  Jeremy A Ross; Hanyin Cheng; Zsuzsanna S Nagy; Jeffrey A Frost; Robert A Kirken
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

5.  Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex.

Authors:  Georgialina Rodriguez; Jeremy A Ross; Zsuzsanna S Nagy; Robert A Kirken
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

6.  Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity.

Authors:  Hanyin Cheng; Jeremy A Ross; Jeffrey A Frost; Robert A Kirken
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

7.  A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.

Authors:  Ling-Yuan Kong; Jun Wei; Amit K Sharma; Jason Barr; Mohamed K Abou-Ghazal; Izabela Fokt; Jeffrey Weinberg; Ganesh Rao; Elizabeth Grimm; Waldemar Priebe; Amy B Heimberger
Journal:  Cancer Immunol Immunother       Date:  2008-11-11       Impact factor: 6.968

8.  Association of Signal Transducer and Activator of Transcription 4 rs10181656 Polymorphism With Rheumatoid Arthritis and Systemic Sclerosis in Khuzestan Province in Southwestern Iran.

Authors:  Fatemeh Ghanavati; Seyed Reza Kazemi Nezhad; Mohammad Reza Hajjari; Mohammad Reza Akhoond
Journal:  Arch Rheumatol       Date:  2019-04-06       Impact factor: 1.472

9.  IL-37 is a fundamental inhibitor of innate immunity.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Jarod A Zepp; Brent E Palmer; Philip Bufler; Charles A Dinarello
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

Review 10.  STAT heterodimers in immunity: A mixed message or a unique signal?

Authors:  Greg M Delgoffe; Dario A A Vignali
Journal:  JAKSTAT       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.